BPC-157, derived from a protective gastric protein, is known for its potential ability to accelerate wound healing, promote angiogenesis (formation of new blood vessels), and protect the gastrointestinal tract
The aging population and growing prevalence of conditions like hypertension and atherosclerosis create demand for options beyond conventional treatments
Gastric bypass patients are at risk for micronutrient deficiencies which lead to in the short term, leading to impaired healing from the surgery, and in the long term, major medical issues such as anemia, scurvy, beriberi, osteoporosis and other conditions
This is where Perfect B operates
BPC-157 is not an MHRA-approved medicine
[1] Because intrinsic-factor-dependent uptake in the distal ileum can be absent in conditions such as autoimmune gastritis, pancreatic insufficiency, or bariatric surgery, the intramuscular or subcutaneous route bypasses gastrointestinal barriers and reliably restores serum concentrations